Segmentation by Product (Gel and ointment, Medical debridement pads, Medical gauzes, Enzymatic debridement products and, Others); and by Wound Type (Diabetic foot ulcers, Pressure ulcers, Burns, and Others) – Global Demand Analysis and Opportunity Outlook 2021-2029
Buy Now
Our in-depth analysis of the global wound debridement market includes the following segments:
By Therapy Type
By Wound Type
Growth Drivers
Challenges
Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. Asia Pacific region is poised to witness lucrative growth during the forecast period due to booming economies, reforms to improve healthcare infrastructure facilities to provide growth of the regional market. Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue, the growth of the region can be attributed to the presence of developed medical infrastructure and increasing patient awareness coupled with rising disposable income and soaring need for quality medical products and services. As per the analysis of American Diabetes Association, diabetes affects 30 million people in the US and more than 415 million people worldwide.
The wound debridement market is further classified on the basis of region as follows:
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Ans: Growing incidence of pressure ulcers, diabetic foot and surgical procedures and rise in the incidence of wound infections are the key factors driving market growth.
Ans: The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.
Ans: High cost of treatment are estimated to hamper market growth.
Ans: The market in Asia Pacific region will provide ample growth opportunities owing to the improving healthcare infrastructure and facilities.
Ans: The major players dominating the wound debridement market are Smith & Nephew, B. Braun Melsungen AG, Zimmer Biomet, Misonix, MediWound among others.
Ans: The company profiles are selected on the basis of revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by product, wound type and region.
Ans: With respect to application, pressure ulcers are anticipated to hold the largest share in the market in owing to increasing incidence of bedsores
Submit Your Request For Proposal (RFP)
